Synerkine adds New members to advisory board

Synerkine Pharma is happy to welcome Dr. Frank Luyten and Dr. Mienke Rijsdijk as new members of their advisory board. They are both very experienced pain specialists and bring critical expertise for Complex Regional Pain Syndrome, the first clinical indication of SK-01. Dr. Huygen is working as an anesthesiologist pain specialist in the University Hospital Erasmus MC in Rotterdam, The Netherlands and is head of the center of pain medicine, a multidisciplinary pain clinic specialized in acute, chronic benign and oncologic pain and palliative care. He is also part-time appointed as full Professor in Pain Medicine at the University Medical Center Utrecht. Dr. Rijsdijk is an anesthesiologist-pain specialist and head of the Pain Clinic of the University Medical Center Utrecht, The Netherlands. She combines her clinical work with translational and interdisciplinary research on several pain-related topics.

Previous
Previous

Synerkine Pharma secures EUR 12.1 million to accelerate novel pain therapeutics towards clinical proof-of-concept

Next
Next

Emilie Rodrigues joins Synerkine Pharma